Home › Funds › Morgan Stanley › NMRA
Morgan Stanley position in NMRA
NEUMORA THERAPEUTICS INC. · Health Care
Latest position (Q2 2026)319.42K sh
Reported value held$543.02K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 400 | $5.64K | New |
| Q4 2023 | 31.08K | $529.90K | Add |
| Q1 2024 | 65.38K | $898.91K | Add |
| Q2 2024 | 156.74K | $1.54M | Add |
| Q3 2024 | 353.69K | $4.67M | Add |
| Q4 2024 | 731.41K | $7.75M | Add |
| Q1 2025 | 852.37K | $852.37K | Add |
| Q1 2025 | 852.37K | $852.37K | Add |
| Q2 2025 | 228.64K | $167.66K | Reduce |
| Q2 2025 | 228.64K | $167.66K | Reduce |
| Q3 2025 | 274.77K | $500.07K | Add |
| Q4 2025 | 238.48K | $426.89K | Reduce |
| Q1 2026 | 503.82K | $982.45K | Add |
| Q2 2026 | 319.42K | $543.02K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NMRA
- BlackRock Inc 7.79M sh · $13.25M · Q2 2026
- Vanguard Group 4.54M sh · $8.13M · Q4 2025
- Fidelity Management & Research (FMR) 3.50M sh · $5.95M · Q2 2026
- Geode Capital Management 2.61M sh · $4.43M · Q2 2026
- Two Sigma Investments 2.24M sh · $3.82M · Q2 2026
- Renaissance Technologies 1.26M sh · $2.15M · Q2 2026
- Marshall Wace 904.46K sh · $1.54M · Q2 2026
- Charles Schwab Investment Management 823.58K sh · $1.40M · Q2 2026
- Northern Trust Corp 800.57K sh · $1.36M · Q2 2026
- Millennium Management 509.21K sh · $865.66K · Q2 2026
- Goldman Sachs Group 303.86K sh · $516.57K · Q2 2026